Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2- HIV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01320176
What this trial is testing

Study to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV Vaccine

Who this might be right for
HIV
Institut Pasteur 36
Testing effectiveness (Phase 2)Study completedNCT01565889
What this trial is testing

Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients.

Who this might be right for
Hepatitis CHIV
Gilead Sciences 52
Early research (Phase 1)UnknownNCT05983874
What this trial is testing

Evaluate the Safety and Immunogenicity of 2 Doses of 100µg BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, Given to a Population of Adults Who Have Received 3 Doses of 300µg BG505 SOSIP.GT1.1 gp140 Vaccine, Adjuvanted

Who this might be right for
Hiv
International AIDS Vaccine Initiative 8
Not applicableNot Yet RecruitingNCT07645352
What this trial is testing

Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 Zimbabwe

Who this might be right for
HIV (Human Immunodeficiency Virus)HPVCervical Precancer+1 more
Fred Hutchinson Cancer Center 300
Testing effectiveness (Phase 2)Study completedNCT00002452
What this trial is testing

A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 30
Not applicableStudy completedNCT01460433
What this trial is testing

Problems With Immune Recovery in the Gut Tissue

Who this might be right for
Human Immunodeficiency Virus
University of Minnesota 21
Post-approval studies (Phase 4)Study completedNCT03667547
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Raltegravir (MK-0518) in Healthy Japanese Male Participants (MK-0518-851)

Who this might be right for
Human Immunodeficiency Virus (HIV) Infection
Merck Sharp & Dohme LLC 12
Not applicableActive Not RecruitingNCT06036238
What this trial is testing

The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 2) (OPAL-Aim 2)

Who this might be right for
HIV/AIDS
University of California, San Francisco 400
Testing effectiveness (Phase 2)Study completedNCT00001087
What this trial is testing

The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Early research (Phase 1)Study completedNCT02715479
What this trial is testing

Evaluate the Effect of BMS-955176 on Pharmacokinetics of Dolutegravir and the Effect of Dolutegravir on the Pharmacokinetics of BMS-955176

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 14
Large-scale testing (Phase 3)Study completedNCT01905059
What this trial is testing

Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa

Who this might be right for
HIV Infection
ANRS, Emerging Infectious Diseases 265
Testing effectiveness (Phase 2)Study completedNCT00004985
What this trial is testing

Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy

Who this might be right for
HIV Infections
Agouron Pharmaceuticals 75
Testing effectiveness (Phase 2)Study completedNCT00490074
What this trial is testing

Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 147
Testing effectiveness (Phase 2)UnknownNCT01666990
What this trial is testing

Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 Infection

Who this might be right for
Human Immunodeficiency Virus
Beijing 302 Hospital 60
Early research (Phase 1)Study completedNCT00000710
What this trial is testing

A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Patients With AIDS or AIDS Related Complex

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Testing effectiveness (Phase 2)Study completedNCT04596878
What this trial is testing

Study of a Group B Streptococcus Vaccine in Pregnant Women Living With HIV and in Pregnant Women Who do Not Have HIV

Who this might be right for
Group B Streptococcal Infection
Minervax ApS 200
Early research (Phase 1)UnknownNCT00280449
What this trial is testing

Two Approaches to Providing HIV/AIDS Services in the Community to People Living With HIV/AIDS

Who this might be right for
HIV Infection
Hamilton Health Sciences Corporation 120
Not applicableActive Not RecruitingNCT05588193
What this trial is testing

ED2PrEP - Patient Focused, Low-burden Strategies for PrEP Uptake Among Emergency Departments

Who this might be right for
HIV
Albert Einstein College of Medicine 1,560
Post-approval studies (Phase 4)Ended earlyNCT00420355
What this trial is testing

Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients

Who this might be right for
HIV Infection
University of Oklahoma 19
Testing effectiveness (Phase 2)Study completedNCT01504841
What this trial is testing

Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 26
Next Page